Related references
Note: Only part of the references are listed.Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease
Nadine Gauchel et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)
Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality
Alexander Leatherdale et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2022)
Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation
Zivile Bekassy et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge
Yaiza Senent et al.
FRONTIERS IN IMMUNOLOGY (2021)
Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population
Farhan S. Cyprian et al.
FRONTIERS IN IMMUNOLOGY (2021)
A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity
Per H. Nilsson et al.
JOURNAL OF IMMUNOLOGY (2021)
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
Bandar Alosaimi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Complement inhibition in severe COVID-19-Blocking C5a seems to be key: Author's reply
Djillali Annane et al.
ECLINICALMEDICINE (2021)
Complement activation in patients with COVID-19: A novel therapeutic target
Massimo Cugno et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
Wenhua Liang et al.
JAMA INTERNAL MEDICINE (2020)
COVID-19: A collision of complement, coagulation and inflammatory pathways
Anoop J. Chauhan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Jia Yu et al.
BLOOD (2020)
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
Julien Carvelli et al.
NATURE (2020)
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study
Djillali Annane et al.
ECLINICALMEDICINE (2020)
Complement C4d-specific antibodies for the diagnosis of lung cancer
Daniel Ajona et al.
Oncotarget (2017)
Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
Myriam Martin et al.
ARTHRITIS RESEARCH & THERAPY (2017)
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis
Andre Struglics et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
Marcin Okroj et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activation
Anna M. Blom et al.
MOLECULAR IMMUNOLOGY (2015)
Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH
Hany Ibrahim Kenawy et al.
FRONTIERS IN IMMUNOLOGY (2015)
An international serum standard for application in assays to detect human complement activation products
Grethe Bergseth et al.
MOLECULAR IMMUNOLOGY (2013)
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway
Michael J. Krisinger et al.
BLOOD (2012)
Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC)
T. E. MOLLNES et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Molecular Intercommunication between the Complement and Coagulation Systems
Umme Amara et al.
JOURNAL OF IMMUNOLOGY (2010)
Generation of C5a in the absence of C3: a new complement activation pathway
Markus Huber-Lang et al.
NATURE MEDICINE (2006)
Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria
P Hillmen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)